GlobeNewswire Inc.··Rosen Law FirmAquestive Faces Securities Lawsuit Over Anaphylm Drug Application Concealment
Rosen Law Firm files class action against Aquestive Therapeutics for allegedly concealing human factors issues in Anaphylm NDA. Investors have until May 4, 2026 deadline.
SMRODDAQSTsecurities class actionlead plaintiff deadline